Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-28

Clinical Trial Update: Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia [NA]

View source ↗

Summary

This document provides a clinical trial update describing a novel transplantation approach for acute leukemia that combines ex vivo T-cell–depleted haploidentic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chimeric Antigen Receptor T-cell Therapy (CAR-T cell therapy)
  • Ex Vivo T-Cell-Depleted Haploidentical Transplantation (haploidentical hematopoietic stem cell transplantation with T-cell depletion)
  • Prophylactic Memory T Cell Infusion (memory T cell infusion)

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Leukemia, Acute Leukemia Refractory | NA | Status: NOT_YET_RECRUITING